These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 10770646)

  • 1. The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models.
    Goldring MB
    Connect Tissue Res; 1999; 40(1):1-11. PubMed ID: 10770646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!).
    Berenbaum F
    Osteoarthritis Cartilage; 2013 Jan; 21(1):16-21. PubMed ID: 23194896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-IL-20 monoclonal antibody inhibited inflammation and protected against cartilage destruction in murine models of osteoarthritis.
    Hsu YH; Yang YY; Huwang MH; Weng YH; Jou IM; Wu PT; Lin TY; Wu LW; Chang MS
    PLoS One; 2017; 12(4):e0175802. PubMed ID: 28426699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticytokine therapy for osteoarthritis.
    Goldring MB
    Expert Opin Biol Ther; 2001 Sep; 1(5):817-29. PubMed ID: 11728217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-inflammatory cytokines: The link between obesity and osteoarthritis.
    Wang T; He C
    Cytokine Growth Factor Rev; 2018 Dec; 44():38-50. PubMed ID: 30340925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoarthritis.
    Goldring MB; Goldring SR
    J Cell Physiol; 2007 Dec; 213(3):626-34. PubMed ID: 17786965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human genome-wide expression analysis reorients the study of inflammatory mediators and biomechanics in osteoarthritis.
    Sandy JD; Chan DD; Trevino RL; Wimmer MA; Plaas A
    Osteoarthritis Cartilage; 2015 Nov; 23(11):1939-45. PubMed ID: 26521740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines in osteoarthritis: mediators or markers of joint destruction?
    Westacott CI; Sharif M
    Semin Arthritis Rheum; 1996 Feb; 25(4):254-72. PubMed ID: 8834014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
    Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
    Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Destruction of articular cartilage].
    Koike T
    Clin Calcium; 2006 Sep; 16(9):1543-47. PubMed ID: 16951481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines as therapeutic targets for osteoarthritis.
    Malemud CJ
    BioDrugs; 2004; 18(1):23-35. PubMed ID: 14733605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cytokines and growth factors in cartilage destruction in osteoarthritis and rheumatoid arthritis.
    van den Berg WB
    Z Rheumatol; 1999 Jun; 58(3):136-41. PubMed ID: 10441840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 is not involved in synovial inflammation and cartilage destruction in collagenase-induced osteoarthritis.
    van Dalen SC; Blom AB; Slöetjes AW; Helsen MM; Roth J; Vogl T; van de Loo FA; Koenders MI; van der Kraan PM; van den Berg WB; van den Bosch MH; van Lent PL
    Osteoarthritis Cartilage; 2017 Mar; 25(3):385-396. PubMed ID: 27654963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chondroprotective drugs in degenerative joint diseases.
    Verbruggen G
    Rheumatology (Oxford); 2006 Feb; 45(2):129-38. PubMed ID: 16278282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of lipocalin-2 (LCN2) in osteoarthritic cartilage is not necessary for cartilage destruction in mice.
    Choi WS; Chun JS
    Osteoarthritis Cartilage; 2017 Mar; 25(3):401-405. PubMed ID: 27477830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine targeting in osteoarthritis.
    Blom AB; van der Kraan PM; van den Berg WB
    Curr Drug Targets; 2007 Feb; 8(2):283-92. PubMed ID: 17305506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-Modifying Osteoarthritis Treatment With Interleukin-1 Receptor Antagonist Gene Therapy in Small and Large Animal Models.
    Nixon AJ; Grol MW; Lang HM; Ruan MZC; Stone A; Begum L; Chen Y; Dawson B; Gannon F; Plutizki S; Lee BHL; Guse K
    Arthritis Rheumatol; 2018 Nov; 70(11):1757-1768. PubMed ID: 30044894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of FOXM1 attenuates inflammatory response in human osteoarthritis chondrocytes.
    Zeng RM; Lu XH; Lin J; Hu J; Rong ZJ; Xu WC; Liu ZW; Zeng WT
    Int Immunopharmacol; 2019 Mar; 68():74-80. PubMed ID: 30612087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.